What's Happening?
At the 2025 American Epilepsy Society Annual Meeting, researchers presented findings on the feasibility of using the HOBSCOTCH mobile app for daily self-reporting by epilepsy patients. The app, part of a randomized controlled trial, collected data from
109 participants, who submitted over 22,000 daily reports. The study highlighted the app's potential to provide detailed insights into intervention dynamics, such as seizure frequency and medication adherence. The app's use in the HOBSCOTCH program, a telehealth-delivered cognitive-behavioral intervention, showed significant within-phase trends in memory strategy use and well-being, indicating its effectiveness in enhancing self-management and quality of life for epilepsy patients.
Why It's Important?
The successful implementation of the HOBSCOTCH app underscores the growing role of digital health technologies in managing chronic conditions like epilepsy. By enabling real-time data collection and personalized care, such apps can improve patient engagement and treatment adherence, potentially leading to better health outcomes. This approach aligns with broader trends in healthcare towards patient-centered, technology-driven solutions. The study's findings could encourage further development and adoption of mobile health applications, transforming how chronic diseases are monitored and managed, and offering new opportunities for research and clinical practice.
